"Egg-based Biology" brand mainly covers cardiovascular and cerebrovascular diseases, tumors, kidneys, infectious diseases and other diseases, and has a leading position in the market of cardiovascular marker detection kits and immune quantitative analyzers. On 20 10, the bedside rapid diagnosis engineering technology center was established, with multiple technical platforms, which can be used for the research of bedside rapid diagnosis instruments and reagents. At the same time, the company also independently established a high-level genetic engineering and antibody engineering platform for the research of antibody drugs.